https://www.nxtpsychedelics.com/news/articles/public-companies/mindset-pharma-ceo-james-lanthier-issues-letter-to-shareholders-discussing-expansion-of-drug-discovery-efforts-into-novel-non-hallucinogenic-therapeutics/
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics